The role of circRNAs and miRNAs in drug resistance and targeted therapy responses in breast cancer

Abstract

MicroRNAs (miRNAs) are small non-coding RNAs comprising 19-24 nucleotides that indirectly control gene expression. In contrast to other non-coding RNAs (ncRNAs), circular RNAs (circRNAs) are defined by their covalently closed loops, forming covalent bonds between the 3’ and 5’ ends. circRNAs regulate gene expression by interacting with miRNAs at transcriptional or post-transcriptional levels. Accordingly, circRNAs and miRNAs control many biological events related to cancer, including cell proliferation, metabolism, cell cycle, and apoptosis. Both circRNAs and miRNAs are involved in the pathogenesis of diseases, such as breast cancer. This review focuses on the latest discoveries on dysregulated circRNAs and miRNAs related to breast cancer, highlighting their potential as biomarkers for clinical diagnosis, prognosis, and chemotherapy response.

Keywords

miRNAs / circRNAs / breast cancer / clinical values

References

[1] Bray F,Sung H.Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.CA Cancer J Clin2024;74:229-63

[2] Nolan E,Visvader JE.Deciphering breast cancer: from biology to the clinic.Cell2023;186:1708-28

[3] Wang J,Luo M.Progression from ductal carcinoma in situ to invasive breast cancer: molecular features and clinical significance.Signal Transduct Target Ther2024;9:83 PMCID:PMC10991592

[4] Purrahman D,Saki N,Kurkowska-Jastrzębska I.Involvement of progranulin (PGRN) in the pathogenesis and prognosis of breast cancer.Cytokine2022;151:155803

[5] He B,Cai Q.miRNA-based biomarkers, therapies, and resistance in Cancer.Int J Biol Sci2020;16:2628-47 PMCID:PMC7415433

[6] Wang J,Sen S.MicroRNA as biomarkers and diagnostics.J Cell Physiol2016;231:25-30 PMCID:PMC8776330

[7] Syed R, Davey MG, Richard V, Miller N, Kerin MJ. Biological implications of MicroRNAs as regulators and biomarkers of therapeutic toxicities in breast cancer.Int J Mol Sci2023;24:12694 PMCID:PMC10454054

[8] Hill M.miRNA interplay: mechanisms and consequences in cancer.Dis Model Mech2021;14:dmm047662 PMCID:PMC8077553

[9] Vishnoi A.miRNA biogenesis and regulation of diseases: an updated overview.Methods Mol Biol2023;2595:1-12

[10] Saliminejad K,Soleymani Fard S.An overview of microRNAs: biology, functions, therapeutics, and analysis methods.J Cell Physiol2019;234:5451-65

[11] Ho PTB,Le LTT.MicroRNA-based diagnosis and therapy.Int J Mol Sci2022;23:7167 PMCID:PMC9266664

[12] Zeng Y,Huang Z.Hsa_circ_0060467 promotes breast cancer liver metastasis by complexing with eIF4A3 and sponging miR-1205.Cell Death Discov2023;9:153 PMCID:PMC10169853

[13] Memczak S,Elefsinioti A.Circular RNAs are a large class of animal RNAs with regulatory potency.Nature2013;495:333-8

[14] Ashwal-Fluss R,Pamudurti NR.circRNA biogenesis competes with pre-mRNA splicing.Mol Cell2014;56:55-66

[15] Yarmishyn AA,Chen CY.Circular RNAs modulate cancer hallmark and molecular pathways to support cancer progression and metastasis.Cancers2022;14:862 PMCID:PMC8869994

[16] Li Y,Yang J.CircTRIM1 encodes TRIM1-269aa to promote chemoresistance and metastasis of TNBC via enhancing CaM-dependent MARCKS translocation and PI3K/AKT/mTOR activation.Mol Cancer2024;23:102 PMCID:PMC11097450

[17] Song X,Chen X,Zhou Y.SRSF1 inhibits ferroptosis and reduces cisplatin chemosensitivity of triple-negative breast cancer cells through the circSEPT9/GCH1 axis.J Proteomics2024;292:105055

[18] Wang H,Shen W.CircRNA (circ)_0007823 contributes to triple-negative breast cancer progression and cisplatin resistance via the miR-182-5p/FOXO1 pathway.Biochem Genet2024;1-13

[19] Michlewski G.Post-transcriptional control of miRNA biogenesis.RNA2019;25:1-16 PMCID:PMC6298569

[20] Matsuyama H.Systems and synthetic microRNA biology: from biogenesis to disease pathogenesis.Int J Mol Sci2019;21:132 PMCID:PMC6981965

[21] Pietrykowska H,Zielezinski A.Biogenesis, conservation, and function of miRNA in liverworts.J Exp Bot2022;73:4528-45 PMCID:PMC9291395

[22] Tafrihi M.MiRNAs: Biology, biogenesis, their web-based tools, and databases.Microrna2019;8:4-27

[23] Do DN,Mathur M,Zhao X.miRNA regulatory functions in farm animal diseases, and biomarker potentials for effective therapies.Int J Mol Sci2021;22:3080 PMCID:PMC8002598

[24] Kilikevicius A,Corey DR.Reexamining assumptions about miRNA-guided gene silencing.Nucleic Acids Res2022;50:617-34 PMCID:PMC8789053

[25] Pu M,Tao Z.Regulatory network of miRNA on its target: coordination between transcriptional and post-transcriptional regulation of gene expression.Cell Mol Life Sci2019;76:441-51 PMCID:PMC11105547

[26] Yang L,Chen LL.Biogenesis and regulatory roles of circular RNAs.Annu Rev Cell Dev Biol2022;38:263-89 PMCID:PMC10119891

[27] Chen LL.The expanding regulatory mechanisms and cellular functions of circular RNAs.Nat Rev Mol Cell Biol2020;21:475-90

[28] Chen LL.The biogenesis and emerging roles of circular RNAs.Nat Rev Mol Cell Biol2016;17:205-11

[29] Huang X,Zhang J,Tang H.Circular RNAs in breast cancer diagnosis, treatment and prognosis.Oncol Res2023;32:241-9 PMCID:PMC10765117

[30] Zhu Y,Li S.CircSMARCA5: a key circular RNA in various human diseases.Front Genet2022;13:921306 PMCID:PMC9445203

[31] Wang Z,Wu P.The circROBO1/KLF5/FUS feedback loop regulates the liver metastasis of breast cancer by inhibiting the selective autophagy of afadin.Mol Cancer2022;21:29 PMCID:PMC8785480

[32] Li Z,Zhang H,Li T.Tumor-suppressive circular RNAs: mechanisms underlying their suppression of tumor occurrence and use as therapeutic targets.Cancer Sci2019;110:3630-8 PMCID:PMC6890437

[33] Li X,Chen LL.The biogenesis, functions, and challenges of circular RNAs.Mol Cell2018;71:428-42

[34] Wu S,Zhu H.A novel axis of circKIF4A-miR-637-STAT3 promotes brain metastasis in triple-negative breast cancer.Cancer Lett2024;581:216508

[35] Zhang M,Zeng X,Liu F.circRNA-miRNA-mRNA in breast cancer.Clin Chim Acta2021;523:120-30

[36] Huang A,Wu Z,Huang Y.Circular RNA-protein interactions: functions, mechanisms, and identification.Theranostics2020;10:3503-17 PMCID:PMC7069073

[37] Li M,Xia T.A five-miRNA panel in plasma was identified for breast cancer diagnosis.Cancer Med2019;8:7006-17 PMCID:PMC6853814

[38] Wang YW,Wang YY.Elevated circRNAs circ_0000745, circ_0001531 and circ_0001640 in human whole blood: potential novel diagnostic biomarkers for breast cancer.Exp Mol Pathol2021;121:104661

[39] Kurozumi S,Narusawa E.Identification of microRNAs associated with histological grade in early-stage invasive breast cancer.Int J Mol Sci2023;25:35 PMCID:PMC10779190

[40] Verma VK,Nair RA.MicroRNA signatures differentiate types, grades, and stages of breast invasive ductal carcinoma (IDC): miRNA-target interacting signaling pathways.Cell Commun Signal2024;22:100 PMCID:PMC10851529

[41] Li X,Wang Y.Plasma-based microRNA signatures in early diagnosis of breast cancer.Mol Genet Genomic Med2020;8:e1092 PMCID:PMC7216817

[42] Jiang W,Ou J,Zhu N.Exosomal circRNA RHOT1 promotes breast cancer progression by targeting miR-204-5p/ PRMT5 axis.Cancer Cell Int2023;23:260 PMCID:PMC10623849

[43] Turco C,Iaiza A.MALAT1-dependent hsa_circ_0076611 regulates translation rate in triple-negative breast cancer.Commun Biol2022;5:598 PMCID:PMC9203778

[44] Yang SJ,Zhong SL.Tumor-derived exosomal circPSMA1 facilitates the tumorigenesis, metastasis, and migration in triple-negative breast cancer (TNBC) through miR-637/Akt1/β-catenin (cyclin D1) axis.Cell Death Dis2021;12:420 PMCID:PMC8080849

[45] Wang B,Wang BY.Exosomal miR-1910-3p promotes proliferation, metastasis, and autophagy of breast cancer cells by targeting MTMR3 and activating the NF-κB signaling pathway.Cancer Lett2020;489:87-99

[46] Shiino S,Shimomura A.Serum miRNA-based prediction of axillary lymph node metastasis in breast cancer.Clin Cancer Res2019;25:1817-27

[47] Wang H,Hu H.microRNA-21 promotes breast cancer proliferation and metastasis by targeting LZTFL1.BMC Cancer2019;19:738 PMCID:PMC6661096

[48] Yuan X,Ling S.Breast cancer exosomes contribute to pre-metastatic niche formation and promote bone metastasis of tumor cells.Theranostics2021;11:1429-45 PMCID:PMC7738874

[49] Alunni-Fabbroni M, Majunke L, Trapp EK, et al; SUCCESS Study Group. Whole blood microRNAs as potential biomarkers in post-operative early breast cancer patients.BMC Cancer2018;18:141 PMCID:PMC5802058

[50] Bao S,Liu J.Genomic instability-derived plasma extracellular vesicle-microRNA signature as a minimally invasive predictor of risk and unfavorable prognosis in breast cancer.J Nanobiotechnology2021;19:22 PMCID:PMC7802300

[51] Raghu A,Rajkumar T.Prognostic implications of microRNA-155, -133a, -21 and -205 in breast cancer patients’ plasma.Microrna2021;10:206-18

[52] Liu B,Fu C.Correlation of microRNA-367 in the clinicopathologic features and prognosis of breast cancer patients.Medicine2021;100:e26103 PMCID:PMC8183767

[53] Záveský L,Weinberger V.Small non-coding RNA profiling in breast cancer: plasma U6 snRNA, miR-451a and miR-548b-5p as novel diagnostic and prognostic biomarkers.Mol Biol Rep2022;49:1955-71

[54] Satomi-Tsushita N,Matsuzaki J.Serum microRNA-based prediction of responsiveness to eribulin in metastatic breast cancer.PLoS One2019;14:e0222024 PMCID:PMC6726239

[55] Wang J,Guan Y.Breast cancer cell-derived microRNA-155 suppresses tumor progression via enhancing immune cell recruitment and antitumor function.J Clin Invest2022;132:e157248 PMCID:PMC9525116

[56] Zhong W,Yuan Y.CircRASSF2 acts as a prognostic factor and promotes breast cancer progression by modulating miR-1205/HOXA1 axis.Bioengineered2021;12:3014-28 PMCID:PMC8806576

[57] Liang G,Mehrpour M.Autophagy-associated circRNA circCDYL augments autophagy and promotes breast cancer progression.Mol Cancer2020;19:65 PMCID:PMC7093993

[58] Garrido-Cano I,Adam-Artigues A.MicroRNAs as a clue to overcome breast cancer treatment resistance.Cancer Metastasis Rev2022;41:77-105 PMCID:PMC8924146

[59] Bao C,Chen D.MiR-93 suppresses tumorigenesis and enhances chemosensitivity of breast cancer via dual targeting E2F1 and CCND1.Cell Death Dis2020;11:618 PMCID:PMC7428045

[60] Cataldo A,Balsari A.miR-302b enhances breast cancer cell sensitivity to cisplatin by regulating E2F1 and the cellular DNA damage response.Oncotarget2016;7:786-97 PMCID:PMC4808033

[61] Papaspyropoulos A,Lagopati N.The role of circular RNAs in DNA damage response and repair.Cancers2021;13:5352 PMCID:PMC8582540

[62] Lu X,Wang M.MicroRNA-140 impedes DNA repair by targeting FEN1 and enhances chemotherapeutic response in breast cancer.Oncogene2020;39:234-47

[63] Lin S,Song X.Intrinsic adriamycin resistance in p53-mutated breast cancer is related to the miR-30c/FANCF/REV1-mediated DNA damage response.Cell Death Dis2019;10:666 PMCID:PMC6739306

[64] Strasser A.Cell death in the origin and treatment of cancer.Mol Cell2020;78:1045-54

[65] Tao L,Zhang SP.MiR-21-5p enhances the progression and paclitaxel resistance in drug-resistant breast cancer cell lines by targeting PDCD4.Neoplasma2019;66:746-55

[66] Duan WJ,Ma Y,Zhen X.MiR-512-3p regulates malignant tumor behavior and multi-drug resistance in breast cancer cells via targeting Livin.Neoplasma2020;67:102-10

[67] Hao J,Lv F.Knockdown of circ_0006528 suppresses cell proliferation, migration, invasion, and adriamycin chemoresistance via regulating the miR-1236-3p/CHD4 axis in breast cancer.J Surg Res2021;260:104-15

[68] Yang W,Yang Y,Yang B.Circ-ABCB10 contributes to paclitaxel resistance in breast cancer through let-7a-5p/DUSP7 axis.Cancer Manag Res2020;12:2327-37 PMCID:PMC7108723

[69] Chen Z,Zhang L.Mammalian drug efflux transporters of the ATP binding cassette (ABC) family in multidrug resistance: a review of the past decade.Cancer Lett2016;370:153-64

[70] Chen Y,Shi L.Combination of 7-O-geranylquercetin and microRNA-451 enhances antitumor effect of Adriamycin by reserving P-gp-mediated drug resistance in breast cancer.Aging2022;14:7156-69 PMCID:PMC9512499

[71] Zhang Z,Luo F.Circular RNA circ-CHI3L1.2 modulates cisplatin resistance of osteosarcoma cells via the miR-340-5p/LPAATβ axis.Hum Cell2021;34:1558-68

[72] Liang H,Lin H,Huang W.circRNA_103615 contributes to tumor progression and cisplatin resistance in NSCLC by regulating ABCB1.Exp Ther Med2021;22:934 PMCID:PMC8281253

[73] Lee JW,Han S,Kim LS.MicroRNA-708-3p mediates metastasis and chemoresistance through inhibition of epithelial-to-mesenchymal transition in breast cancer.Cancer Sci2018;109:1404-13 PMCID:PMC5980212

[74] Wang G,Liu H.Loss of miR-873 contributes to gemcitabine resistance in triple-negative breast cancer via targeting ZEB1.Oncol Lett2019;18:3837-44 PMCID:PMC6757270

[75] Liu YY,Du WZ.Circular RNA circ-PVT1 contributes to paclitaxel resistance of gastric cancer cells through the regulation of ZEB1 expression by sponging miR-124-3p.Biosci Rep2019;39:BSR20193045 PMCID:PMC6928529

[76] Jhaveri K.Current and emerging treatment approaches for hormone receptor-positive/human epidermal growth factor receptor 2-negative metastatic breast cancer.Cancer Treat Rev2024;123:102670

[77] Nakagawa T,Ogawa A.Bone marrow carcinomatosis in a stage IV breast cancer patient treated by letrozole as first-line endocrine therapy.Case Rep Oncol2022;15:436-41 PMCID:PMC9149407

[78] Boscolo Bielo L,Nicolò E.The evolving landscape of metastatic HER2-positive, hormone receptor-positive Breast Cancer.Cancer Treat Rev2024;128:102761

[79] He YJ,Ji MH.miR-342 is associated with estrogen receptor-α expression and response to tamoxifen in breast cancer.Exp Ther Med2013;5:813-8 PMCID:PMC3570195

[80] Yi J,Hu GS.CircPVT1 promotes ER-positive breast tumorigenesis and drug resistance by targeting ESR1 and MAVS.EMBO J2023;42:e112408 PMCID:PMC10183818

[81] Ward A,Balwierz A.MicroRNA-519a is a novel oncomir conferring tamoxifen resistance by targeting a network of tumour-suppressor genes in ER+ breast cancer.J Pathol2014;233:368-79 PMCID:PMC4298809

[82] Zheng L,Li X.miR-125a-3p inhibits ERα transactivation and overrides tamoxifen resistance by targeting CDK3 in estrogen receptor-positive breast cancer.FASEB J2018;32:588-600

[83] Chen J,Zhang J.CircRNA_0044556 diminishes the sensitivity of triple-negative breast cancer cells to adriamycin by sponging miR-145 and regulating NRAS.Mol Med Rep2022;25:51 PMCID:PMC8711030

[84] Misir S,Petrović N,Hepokur C.circRNAs in drug resistance of breast cancer.Oncol Res2022;30:157-72 PMCID:PMC10208077

[85] Ye X,Zhu H.MiR-221 promotes trastuzumab-resistance and metastasis in HER2-positive breast cancers by targeting PTEN.BMB Rep2014;47:268-73 PMCID:PMC4163864

[86] Wang S,Li Q,Feng X.A novel circular RNA confers trastuzumab resistance in human epidermal growth factor receptor 2-positive breast cancer through regulating ferroptosis.Environ Toxicol2022;37:1597-607

[87] Ling Y,Lin Q.circCDYL2 promotes trastuzumab resistance via sustaining HER2 downstream signaling in breast cancer.Mol Cancer2022;21:8 PMCID:PMC8722291